Surfactant-Based Homogeneous Assay for the Measurement of Triglyceride Concentrations in VLDL and Intermediate-Density Lipoprotein
Open Access
- 1 October 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (10), 1804-1810
- https://doi.org/10.1373/clinchem.2005.049304
Abstract
Background: Existing studies have demonstrated the clinical significance of triglyceride content in VLDL (VLDL-TG) and intermediate-density lipoprotein (IDL-TG). We developed a homogeneous assay protocol to directly measure VLDL-TG. Methods: Possible reagents and conditions for measuring VLDL-TG were comprehensively tested, and the “best” combination was determined. Healthy persons were instructed to consume a fatty meal after 15-h overnight fasting. Serum VLDL-TG + IDL-TG concentrations were measured using the proposed method. Patients with serum LDL-cholesterol concentrations ≥3.62 mmol/L (140 mg/dL) were administered simvastatin at a daily dose of 5 mg, and serum VLDL-TG concentrations were then measured. Results: The combination of 2 nonionic surfactants played an important role in differentiating VLDL and IDL from other lipoproteins, probably via specific interactions with phospholipids and apolipoproteins. The regression line of the proposed method (y) and the ultracentrifugal assay (x) was: y = 0.98x + 0.31 mmol/L (r = 0.98; n = 73; P <0.05). The difference between postprandial total TG and VLDL-TG concentrations was statistically significant (P <0.05). After 8 weeks of therapy with simvastatin, total TG and LDL-cholesterol concentrations were 13.6% and 26.3% lower, respectively (P <0.05), whereas VLDL-TG did not show any significant decrease. Conclusion: Our homogeneous method can measure TG content in VLDL and IDL.Keywords
This publication has 20 references indexed in Scilit:
- Do Total and High Density Lipoprotein Cholesterol and Triglycerides Act Independently in the Prediction of Ischemic Heart Disease?Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Accumulation of Apolipoprotein C-I–Rich and Cholesterol-Rich VLDL Remnants During Exaggerated Postprandial Triglyceridemia in Normolipidemic Patients With Coronary Artery DiseaseCirculation, 2000
- Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Clinical and biochemical factors associated with prognosis after myocardial infarction at a young ageJournal of the American College of Cardiology, 1994
- Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of diseaseThe Lancet, 1994
- Plasma triglyceride and coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Hypertriglyceridemia and carbohydrate intolerance: Interrelations and therapeutic implicationsThe American Journal of Cardiology, 1986
- Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.Circulation, 1977
- Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjectsAtherosclerosis, 1977